Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Diabetes. 2016 Aug 2;65(10):3212–3217. doi: 10.2337/db16-0628

Figure 1.

Figure 1

Kaplan-Meier plot comparing the proportion of p.R114W heterozygotes that are diabetic to patients with other pathogenic HNF4A mutations (at each age where data is available). Panel A includes all probands and family members – the hazard ratio for diabetes is 0.659 (P=0.013) comparing p.R114W heterozygotes to patients with other HNF4A mutations. Panel B includes only family members to remove the effect of ascertainment bias in the probands – the hazard ratio for diabetes is 0.553 (P=0.013) comparing p.R114W heterozygotes to patients with other HNF4A mutations.